Tilting the balance of dose modification for oral anticancer drugs?

J Clin Oncol. 2014 May 20;32(15):1537-9. doi: 10.1200/JCO.2014.55.2372. Epub 2014 Apr 7.

Authors

Philippe L Bedard¹, Lillian L Siu²

Affiliations

¹ Princess Margaret Cancer Centre, University Health Network; University of Toronto, Toronto, ON, Canada.
² Princess Margaret Cancer Centre, University Health Network; University of Toronto, Toronto, ON, Canada lillian.siu@uhn.ca.

PMID: 24711547
DOI: 10.1200/JCO.2014.55.2372

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antineoplastic Agents / administration & dosage*
Clinical Trials as Topic / methods*
Comparative Effectiveness Research*
Drug Dosage Calculations*
Humans
Neoplasms / drug therapy*
Research Design*

Substances

Antineoplastic Agents